In patients with NAFLD, Fetuin-A levels were associated with the severity of steatosis, were influenced by genetic risk factors for hepatic fat accumulation and also correlated with insulin resistance and metabolic syndrome features [199]. This evidence concerns the gene AHSG and metabolic syndrome.